The CEO of CBBC member company AstraZeneca, Pascal Soriot, has said that China is “completely open” for pharma investment, and added that there has been an “explosion” of biotech companies in China. “It’s hard to not be impressed by the progress that has been made in China over the last few years,” he said in April. Some Western governments have been publicly decrying the threat of “economic coercion” from China, …
Tag:
AstraZeneca
In 2019, AstraZeneca China launched the I-Campus – a health-tech incubator – in collaboration with the Wuxi local government. Here Michael Lai, General Manager of AstraZeneca China, talks more about the project and China’s growing healthcare sector What is the I-Campus exactly? I·Campus is a one-stop incubation platform for life science innovation companies. It will land, incubate, accelerate, and scale up both domestic and overseas life science companies with support …
- HealthcareUncategorized
Leon Wang, AstraZeneca’s Executive Vice-President for International and President of China, discusses China’s healthcare industry
AstraZeneca has been in China now for 25 years, what have you learnt along the way? We are always learning as China is rapidly evolving. As new challenges and opportunities continually drive AstraZeneca’s objective to reshape healthcare in China, one important aspect we have learned is to lead change in tandem with our partners. While we continue to focus on understanding and tackling the critical unmet health needs in China, …